ArticleCase reports in ophthalmology
Benign Yellow Dot Maculopathy in a Palestinian Child: A Case Report.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Benign yellow dot maculopathy (BYDM) is a recently recognized macular phenotype, first described in 2017. It may occur sporadically or follow a familial pattern. The condition is characterized by a rare, asymptomatic, early-onset, nonprogressive maculopathy, with multiple yellow dots at the macula and minimal or no functional impairment. Owing to its benign and frequently asymptomatic course, this condition is likely underdiagnosed and underreported. Case Presentation: We report a 6-year-old Palestinian patient who was incidentally found to have bilateral, discrete yellow dots confined to the macular region, associated with reduced visual acuity. A comprehensive ophthalmic evaluation was performed. Multimodal imaging, including optical coherence tomography, demonstrated preserved retinal architecture, while electrophysiological testing showed normal global retinal function, supporting a benign, nonprogressive phenotype. Following careful exclusion of other inherited and acquired macular disorders, a diagnosis of BYDM was established. Conclusion: This report documents a case of BYDM in a Palestinian patient and contributes to the limited existing literature on this rare macular phenotype. To our knowledge, this is the first reported case from a Palestinian patient. Recognition of this entity is important to avoid misdiagnosis, unnecessary investigations, and patient anxiety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.